Results 251 to 260 of about 91,203 (305)
Structure-Guided Identification and Evaluation of Epalrestat and Ranirestat-Like Compounds Against Aldose Reductase: Therapeutic Management of Diabetic Neuropathy. [PDF]
Khan MS, Yadav DK, Shahwan M, Shamsi A.
europepmc +1 more source
Corneal Nerve Morphology in Painful Diabetic Neuropathy: A Meta-Analysis of In Vivo Confocal Microscopy Studies. [PDF]
Vidyasagar P +4 more
europepmc +1 more source
Changes of intestinal microbiome and its relationship with painful diabetic neuropathy in rats. [PDF]
Jia S, Mi H, Su Y, Liu Y, Ming Z, Lin J.
europepmc +1 more source
Evaluation and Management of Diabetic Neuropathy from the Perspective of People with Diabetes
K. Ramesh Babu +4 more
openalex +2 more sources
Feasibility and Tolerability of Controllable Pulse Parameter Transcranial Magnetic Stimulation in Patients with Painful Diabetic Neuropathy: A Case Series Study. [PDF]
Park J +5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Medical Clinics of North America, 1998
Better clinical characteristics and a standardized approach to the definition of neuropathy has enabled us to define more precisely the natural history of diabetic neuropathy. Detailed studies on the pathology and pathogenesis have allowed dissection of important pathogenetic pathways.
A J, Boulton, R A, Malik
openaire +5 more sources
Better clinical characteristics and a standardized approach to the definition of neuropathy has enabled us to define more precisely the natural history of diabetic neuropathy. Detailed studies on the pathology and pathogenesis have allowed dissection of important pathogenetic pathways.
A J, Boulton, R A, Malik
openaire +5 more sources
Experimental and Clinical Endocrinology & Diabetes, 2014
Neuropathies related to diabetes mellitus can affect 60-70% of patients with diabetes. These can include peripheral polyneuropathies, mononeuropathies, and autonomic neuropathies. Control of glucose, lipids, and hypertension and cessation of smoking can limit onset and progression of these neuropathies. Besides control of the above listed risk factors,
Dan, Ziegler +3 more
openaire +7 more sources
Neuropathies related to diabetes mellitus can affect 60-70% of patients with diabetes. These can include peripheral polyneuropathies, mononeuropathies, and autonomic neuropathies. Control of glucose, lipids, and hypertension and cessation of smoking can limit onset and progression of these neuropathies. Besides control of the above listed risk factors,
Dan, Ziegler +3 more
openaire +7 more sources

